The use of sugammadex in a patient with myotonic dystrophy.
Yuka
Y
Matsuki
Munetaka
M
Hirose
Mari
M
Tabata
Yasunari
Y
Nobukawa
Kenji
K
Shigemi
D000732:Androstanols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D009223:Myotonic Dystrophy / Q000150:complications*; D019148:Neuromuscular Blockade / Q000379:methods*; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D010048:Ovarian Cysts / Q000601:surgery; D000077123:Rocuronium; D000077122:Sugammadex; D055815:Young Adult; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium